237 related articles for article (PubMed ID: 23768930)
1. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
Altman JK; Rademaker A; Cull E; Weitner BB; Ofran Y; Rosenblat TL; Haidau A; Park JH; Ram SL; Orsini JM; Sandhu S; Catchatourian R; Trifilio SM; Adel NG; Frankfurt O; Stein EM; Mallios G; Deblasio T; Jurcic JG; Nimer S; Peterson LC; Kwaan HC; Rowe JM; Douer D; Tallman MS
Leuk Res; 2013 Sep; 37(9):1004-9. PubMed ID: 23768930
[TBL] [Abstract][Full Text] [Related]
2. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
Ohno R; Ohnishi K; Takeshita A; Tanimoto M; Murakami H; Kanamaru A; Asou N; Kobayashi T; Kuriyama K; Ohmoto E
Leukemia; 1994; 8 Suppl 3():S64-9. PubMed ID: 7808028
[TBL] [Abstract][Full Text] [Related]
3. Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia.
Leblebjian H; DeAngelo DJ; Skirvin JA; Stone RM; Wadleigh M; Werner L; Neuberg DS; Bartel S; McDonnell AM
Leuk Res; 2013 Jul; 37(7):747-51. PubMed ID: 23643326
[TBL] [Abstract][Full Text] [Related]
4. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
[TBL] [Abstract][Full Text] [Related]
5. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid-induced myositis in a child with acute promyelocytic leukemia.
Citak FE; Ezer U; Akkaya E; Ozbulbul N; Bahce M; Kurekci AE
Haematologica; 2006 Aug; 91(8 Suppl):ECR35. PubMed ID: 16923519
[TBL] [Abstract][Full Text] [Related]
7. All-trans retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).
Chim CS; Kwong YL; Liang R; Chu YC; Chan CH; Chan LC; Wong KF; Chan TK
Hematol Oncol; 1996 Sep; 14(3):147-54. PubMed ID: 9119359
[TBL] [Abstract][Full Text] [Related]
8. Role of all-trans-retinoic acid (ATRA) in the consolidation therapy of acute promyelocytic leukaemia (APL).
Gupta V; Yi QL; Brandwein J; Lipton JH; Messner HA; Schuh AC; Wells RA; Minden MD
Leuk Res; 2005 Jan; 29(1):113-4. PubMed ID: 15541484
[TBL] [Abstract][Full Text] [Related]
9. Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid.
Escudier SM; Kantarjian HM; Estey EH
Leuk Lymphoma; 1996 Feb; 20(5-6):435-9. PubMed ID: 8833399
[TBL] [Abstract][Full Text] [Related]
10. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia.
Raza S; Ullah K; Ahmed P; Khan B
J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891
[TBL] [Abstract][Full Text] [Related]
11. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
12. Use of all-trans retinoic acid in combination with arsenic trioxide for remission induction in patients with newly diagnosed acute promyelocytic leukemia and for consolidation/maintenance in CR patients.
Dai CW; Zhang GS; Shen JK; Zheng WL; Pei MF; Xu YX; Cao YX; Yi Y; Yang JJ; Peng HL; Zhong HY; Li RJ
Acta Haematol; 2009; 121(1):1-8. PubMed ID: 19246888
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
14. [Hemostatic changes during the treatment of acute promyelocytic leukemia with all-transretinoic acid].
Medvedeva NA; Cherepanova VV; Tarasova LN; Kudriavtseva AV; Kostin AI; Kolupaeva OR
Ter Arkh; 2000; 72(7):27-31. PubMed ID: 10983317
[TBL] [Abstract][Full Text] [Related]
15. The efficacy and safety of arsenic trioxide with or without all-trans retinoic acid for the treatment of acute promyelocytic leukemia: a meta-analysis.
Wang H; Chen XY; Wang BS; Rong ZX; Qi H; Chen HZ
Leuk Res; 2011 Sep; 35(9):1170-7. PubMed ID: 21774985
[TBL] [Abstract][Full Text] [Related]
16. Treatment with all-trans retinoic acid in acute promyelocytic leukemia reduces early deaths in children.
Mann G; Reinhardt D; Ritter J; Hermann J; Schmitt K; Gadner H; Creutzig U
Ann Hematol; 2001 Jul; 80(7):417-22. PubMed ID: 11529468
[TBL] [Abstract][Full Text] [Related]
17. Early onset of chemotherapy can reduce the incidence of ATRA syndrome in newly diagnosed acute promyelocytic leukemia (APL) with low white blood cell counts: results from APL 93 trial.
de Botton S; Chevret S; Coiteux V; Dombret H; Sanz M; San Miguel J; Caillot D; Vekhoff A; Gardembas M; Stamatoulas A; Conde E; Guerci A; Gardin C; Fey M; Cony Makhoul D; Reman O; de la Serna J; Lefrere F; Chomienne C; Degos L; Fenaux P;
Leukemia; 2003 Feb; 17(2):339-42. PubMed ID: 12592333
[TBL] [Abstract][Full Text] [Related]
18. Delay in the administration of all-trans retinoic acid and its effects on early mortality in acute promyelocytic leukemia: final results of a multicentric study in the United States.
Rashidi A; Riley M; Goldin TA; Sayedian F; Bayerl MG; Aguilera NS; Vos JA; Goudar RK; Fisher SI
Leuk Res; 2014 Sep; 38(9):1036-40. PubMed ID: 25035073
[TBL] [Abstract][Full Text] [Related]
19. Occurrence of cerebellar thrombohemorrhage during all-trans retinoic acid (ATRA) therapy in a case of acute promyelocytic leukemia.
Parma M; Casaroli I; Pogliani EM
Haematologica; 1996; 81(4):379-80. PubMed ID: 8870387
[No Abstract] [Full Text] [Related]
20. Acute renal failure during ATRA treatment.
Yarali N; Tavil B; Kara A; Ozkasap S; Tunç B
Pediatr Hematol Oncol; 2008 Mar; 25(2):115-8. PubMed ID: 18363177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
